[HTML][HTML] Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy

X Mao, S Wu, D Huang, C Li - Acta Pharmaceutica Sinica B, 2024 - Elsevier
Despite the considerable advancements in chemotherapy as a cornerstone modality in
cancer treatment, the prevalence of complications and pre-existing diseases is on the rise …

[HTML][HTML] Using wearable inertial sensors to assess mobility of patients with hematologic cancer and associations with chemotherapy-related symptoms before …

MB Skiba, G Harker, C Guidarelli, M El-Gohary… - JMIR cancer, 2022 - cancer.jmir.org
Background Wearable sensors could be a simple way to quantify and characterize mobility
in patients with hematologic cancer scheduled to receive autologous hematopoietic stem …

[HTML][HTML] Determination of the Influence of Peripheral Neuropathy Symptoms on Quality of Life in Breast Cancer Patients: A Cross-Sectional Study with Four Follow-Ups

B Kurt, ZS Karslı, BÖÇ Öksüzoğlu, E Öztürk… - … Nightingale Journal of …, 2023 - ncbi.nlm.nih.gov
Aim: This study aims to evaluate the impact of peripheral neuropathy symptoms throughout
with monthly follow-ups during 4 months of paclitaxel treatment. Methods: This prospective …

[PDF][PDF] FNJN

B Kurt, ZS Karslı, BÖÇ Öksüzoğlu, E Öztürk… - 2023 - fnjn.org
AIM: This study aims to evaluate the impact of peripheral neuropathy symptoms throughout
with monthly follow-ups during 4 months of paclitaxel treatment. METHODS: This …

[PDF][PDF] Remissrunda–Nationellt vårdprogram för cancerrehabilitering

Y Hellstadius - cancercentrum.se
Remissionversion nationellt vårdprogram cancerrehabilitering Page 1 Regionala cancercentrum
i samverkan Sveriges Kommuner och Regioner | 118 82 Stockholm Besök: Hornsgatan 20 …

[引用][C] Remissrunda–Nationellt vårdprogram för cancerrehabilitering

G Eckerdal